In this article, we will look at the 15 Most Promising Stocks to Buy Right Now.
Promising quality growth stocks are getting more attention as investors look for companies where growth expectations are still backed by earnings momentum, not just market excitement. For this list, the focus is on stocks forecasted to grow earnings by at least 30% annually over the next five years and carrying Buy ratings from analysts, helping narrow the market to names where Wall Street still sees room for meaningful earnings expansion.
BlackRock says “earnings are broadening beyond a highly concentrated group of mega-cap technology names tied to AI,” giving investors “greater choice for sourcing growth.” Capital Group makes a similar point, saying markets are shifting toward “a more balanced one with a broadening opportunity set,” where “active stock selection, supported by deep research,” has become more important. The firm also notes that leading AI-related companies are supported by “solid earnings growth” and “strong free cash flow.” T. Rowe Price adds that “long-term growth prospects remain compelling,” but investors should focus on “execution, financial resilience, and clear paths to monetization.”
Against this backdrop, the most promising stocks deserve a closer look. With that in mind, let’s take a look at the 15 Most Promising Stocks to Buy Right Now.
Our Methodology
We used the Finviz screener to identify promising stocks that are forecasted to grow their earnings by over 30% annually in the next 5 years and carry a Buy or better rating from analysts. We then limited our final selection to companies that have recently reported noteworthy developments likely to impact investor sentiment. These stocks are also popular among analysts and elite hedge funds.
Why are we interested in the stocks that hedge funds pile into? The reason is simple: our research has shown that we can outperform the market by imitating the top stock picks of the best hedge funds. Insider Monkey’s quarterly newsletter’s strategy selects 14 small-cap and large-cap stocks every quarter and has returned 599.2% since May 2014, beating its benchmark by 372 percentage points (see more details here).
15. Lam Research Corporation (NASDAQ:LRCX)
On May 27, 2026, Mizuho raised the firm’s price target on Lam Research Corporation (NASDAQ:LRCX) to $380 from $330 and maintained an Outperform rating on the shares. Mizuho raised its wafer fab equipment spending estimate for 2026 to $153B from $142B and for 2027 to $190B from $163B. The firm said current earnings estimates for Lam Research, Applied Materials, and MKS are underestimated, citing NAND node transitions, TSMC spending, and strength in DRAM and high bandwidth memory pricing.
On May 18, 2026, Morgan Stanley upgraded Lam Research Corporation to Overweight from Equal Weight with a price target of $331, up from $293. Morgan Stanley said DRAM wafer fab equipment revisions have narrowed and that it is now more positive on NAND wafer fab equipment revisions. The firm cited confidence in Lam’s 2027 share gains for the upgrade and paired the move with a downgrade of Applied Materials (AMAT).
Earlier in May, B. Riley raised the firm’s price target on Lam Research Corporation to $385 from $350 and maintained a Buy rating on the shares. B. Riley said AI investment is accelerating faster than expected, with demand from hyperscalers and neo-cloud providers driving higher 2026-2028 capital expenditure estimates. The firm also cited tightening supply-demand fundamentals, strong semiconductor EPS revisions, and elevated sector valuations.
Lam Research Corporation designs, manufactures, markets, refurbishes, and services semiconductor processing equipment used in integrated circuit fabrication across the United States, China, Korea, Taiwan, Japan, Southeast Asia, and Europe.
14. Block, Inc. (NYSE:XYZ)
On May 29, 2026, Morgan Stanley analyst James Faucette raised the firm’s price target on Block, Inc. (NYSE:XYZ) to $98 from $96 and maintained an Overweight rating on the shares. Faucette cited Morgan Stanley’s proprietary AlphaWise survey of about 274 small and medium-sized businesses, which showed momentum for Block, Shopify (SHOP), and Stripe.
On May 27, 2026, Truist raised the firm’s price target on Block, Inc. to $82 from $81 and maintained a Buy rating on the shares as part of a broader note on payments names. Truist said management was prudent in setting guidance and continues to believe Block can be a good beat-and-raise story throughout the year.
On May 26, Magnolia Soap & Bath Co. selected Block’s Square as its unified commerce platform for more than 50 locations across 17 states, as the brand invests in scalable infrastructure to support franchisees, maintain brand consistency, and support its in-store experience.
Block, Inc. builds ecosystems focused on commerce and financial products and services in the United States and internationally.
13. Sterling Infrastructure, Inc. (NASDAQ:STRL)
On May 28, 2026, Oppenheimer analyst Brent Thielman initiated coverage of Sterling Infrastructure, Inc. (NASDAQ:STRL) with an Outperform rating and a $950 price target. Thielman said Sterling has transformed through acquisitions into an “industry margin-leading provider” of specialty services for major infrastructure projects, especially those tied to technology and manufacturing industry leaders. Oppenheimer added that Sterling’s expansion from civil services and site development into inside electrical construction should allow the company to capture more customer wallet share.
On May 6, 2026, KeyBanc raised the firm’s price target on Sterling Infrastructure, Inc. to $889 from $572 and maintained an Overweight rating on the shares. KeyBanc cited very strong Q1 results, robust bookings, improving margins, strong free cash flow, and a net cash balance sheet. The firm said E-Infra gets most of the attention, but Transportation and the balance sheet are also improving, giving Sterling opportunities for further M&A in E-Infra or MEP as it expands into more geographies.
Earlier in May, Sterling Infrastructure, Inc. reported Q1 EPS of $3.59, ahead of the consensus estimate of $2.19. Revenue totaled $825.7M, above the consensus estimate of $591.97M. Backlog stood at $3.80B as of March 31, up 78% from the prior-year period. CEO Joe Cutillo said Sterling was off to an “exceptional start” in 2026, with adjusted net income up 122%, revenue growth of 92%, organic growth of more than 55%, adjusted EBITDA margin above 20%, and operating cash flow of $166M.
Sterling Infrastructure, Inc. provides e-infrastructure, transportation, and building solutions in the United States.
12. Hyatt Hotels Corporation (NYSE:H)
On May 29, 2026, Mizuho raised the firm’s price target on Hyatt Hotels Corporation (NYSE:H) to $221 from $219 and maintained an Outperform rating on the shares following the company’s investor day. Mizuho came away “incrementally more positive,” saying Hyatt’s underlying business has the opportunity to accelerate, while its valuation and Street estimates largely do not reflect that.
On the same day, JPMorgan raised the firm’s price target on Hyatt Hotels Corporation to $205 from $186 and maintained an Overweight rating on the shares. JPMorgan came away “incrementally positive” on Hyatt’s free cash flow growth trajectory and its ability to execute on fiscal 2028 targets.
Truist analyst C. Patrick Scholes also raised the firm’s price target on Hyatt Hotels Corporation to $187 from $181 and maintained a Buy rating as part of a broader note on Lodging and Lodging REITs.
Last month, Hyatt Hotels Corporation reported Q1 adjusted EPS of 63c, ahead of the consensus estimate of 57c. Comparable system-wide hotels RevPAR rose 5.4% year-over-year. Q1 adjusted EBITDA was $266M, up 2.1% year-over-year, or 2.9% after adjusting for assets sold in 2025. CEO Mark Hoplamazian said the results reflected strength in Hyatt’s core fee business and the resilience of its portfolio, while citing its customer base, pipeline, and loyalty program.
Hyatt Hotels Corporation operates as a hospitality company in the United States and internationally.
11. Neurocrine Biosciences, Inc. (NASDAQ:NBIX)
On May 29, 2026, RBC Capital raised the firm’s price target on Neurocrine Biosciences, Inc. (NASDAQ:NBIX) to $183 from $180 and maintained an Outperform rating on the shares. RBC said the stock has rebounded after a strong Q1, though concerns remain that Crenessity uptake could hit a near-term ceiling. RBC also said its endocrinologist survey suggests room for near- and long-term growth, including expected utilization growth among doctors not currently using the drug.
On May 21, 2026, Bernstein analyst Jeffrey Walch initiated coverage of Neurocrine Biosciences, Inc. with an Outperform rating and a $221 price target. Walch described Neurocrine as one of the more promising names in Bernstein’s initial coverage group of mid-cap biopharmaceutical companies, noting that the company’s two key medicines are already approved and have a long runway until loss-of-exclusivity. Bernstein added that upside could come as the market gains more certainty around future market share and a Phase 3 trial readout.
Earlier in May, Neurocrine Biosciences, Inc. reported Q1 adjusted EPS of $1.94, ahead of the consensus estimate of $1.70. Revenue totaled $811M, above the consensus estimate of $767.88M. CEO Kyle Gano said the quarter reflected “continued momentum” across the commercial portfolio, with net product sales up 44% year-over-year, driven by demand for INGREZZA and CRENESSITY. Gano also cited the agreement to acquire Soleno Therapeutics and the company’s pipeline.
Neurocrine Biosciences, Inc. discovers, develops, and commercializes pharmaceuticals for neurological, psychiatric, endocrine, and immunological disorders in the United States and internationally.
10. American Healthcare REIT, Inc. (NYSE:AHR)
On May 28, 2026, KeyBanc raised the firm’s price target on American Healthcare REIT, Inc. (NYSE:AHR) to $58 from $55 and maintained an Overweight rating on the shares. KeyBanc said American Healthcare REIT remains well-positioned to benefit from strength across its RIDEA segments and a fortified balance sheet following last week’s equity issuance. The firm also raised its 2026 NFFO estimate by about 5% to $2.11 per share and its 2027 NFFO estimate by 6% to $2.40 per share, citing upside to the company’s 2026 SSNOI growth outlook, earnings accretion from awarded acquisitions, and a robust investment pipeline.
On May 26, 2026, RBC Capital analyst Michael Carroll raised the firm’s price target on American Healthcare REIT, Inc. to $56 from $54 and maintained an Outperform rating on the shares. Carroll said the company delivered a solid earnings report, highlighted by healthy organic growth and an attractive investment pace.
Earlier in May, American Healthcare REIT, Inc. reported Q1 normalized FFO of 50c, ahead of the consensus estimate of 47c. Revenue totaled $650.77M, below the consensus estimate of $687.04M. CEO Jeff Hanson said the quarter reflected an “exceptionally strong period” across core metrics, including the company’s ninth consecutive quarter of double-digit Same-Store NOI growth, efficient capital formation and deployment, a strengthened balance sheet, and a raise to full-year 2026 Same-Store NOI growth and NFFO per share guidance.
American Healthcare REIT, Inc. owns and operates a diversified portfolio of clinical healthcare real estate.
9. Ondas Inc. (NASDAQ:ONDS)
On May 29, 2026, Ondas Inc. (NASDAQ:ONDS) said it secured more than $30M in new orders during May across its defense, security, and autonomous technology platform. The May order momentum brings Ondas’ Q2-to-date orders to more than $110M. The company said the orders support a growing backlog and span its system-based defense and security businesses, including Air Defense and C-UAS solutions, loitering munitions and one-way attack systems, ISR systems, UGVs, robotic defense systems, and mission-critical security technologies.
On May 14, 2026, Ondas Inc. reported Q1 revenue of $50.1M, above the consensus estimate of $39.36M. Chairman and CEO Eric Brock said the company delivered “record results” in the quarter, with revenue rising tenfold year-over-year. Brock also said Ondas’ system-of-systems platform is scaling, while its product companies were adjusted EBITDA positive in the first quarter, six months ahead of target. Ondas ended the quarter with a backlog of $457 million and raised its full-year revenue outlook to at least $390 million.
Ondas said it expects continued strong momentum in 2026 and raised its full-year revenue target to at least $390 million, representing a 670% increase from 2025 results. The company said growth is expected to be broad-based across its product portfolio and supported by $457 million in backlog. Ondas also said adjusted EBITDA losses are expected to remain elevated in Q2 2026, likely marking the peak, before improving through the year as revenue, gross profit, and operating scale increase. The company now expects OAS-adjusted EBITDA profitability by Q1 2027, compared with its prior expectation of Q3 2027, and maintains its expectation of company-wide adjusted EBITDA profitability by Q1 2028.
Ondas Inc. provides private wireless, drone, and automated data solutions in the United States and internationally.
8. Global-E Online Ltd. (NASDAQ:GLBE)
On May 26, 2026, Jefferies reiterated a Buy rating and $40 price target on Global-E Online Ltd. (NASDAQ:GLBE) after the company agreed to acquire Passport. Jefferies said Passport will add advanced shipping solutions to Global-e’s platform, strengthen return capabilities, and expand the company’s total addressable market. The firm also said the strategic rationale for the deal makes sense and improves Global-e’s competitive positioning.
A day earlier, Global-e Online announced a definitive agreement to acquire Passport Global, a U.S.-based cross-border e-commerce logistics and solutions company. Global-e said the acquisition will strengthen its logistics capabilities through standard shipping solutions supported by an asset-light, multi-carrier network across cross-border, domestic, and last-mile deliveries. Passport is expected to generate approximately $100 million in revenue in calendar year 2026, with a growth rate expected to slightly exceed Global-e’s for the year. The transaction is expected to close in early July 2026, subject to customary closing conditions, including regulatory approvals.
On May 14, 2026, BofA lowered the firm’s price target on Global-e Online to $40 from $43 and maintained a Buy rating on the shares. BofA said that, looking “beyond the noise” in Q1, the results strengthen its conviction that Global-e is on track to become the de facto platform powering an estimated $114B cross-border eCommerce market by 2030.
Global-E Online Ltd. provides a direct-to-consumer cross-border e-commerce platform in Israel, the United Kingdom, the United States, and internationally.
7. Array Digital Infrastructure, Inc. (NYSE:AD)
On May 26, 2026, JPMorgan lowered the firm’s price target on Array Digital Infrastructure, Inc. (NYSE:AD) to $54 from $60 and maintained an Overweight rating on the shares. JPMorgan said the company’s tower momentum remains strong and its spectrum monetization is progressing. The firm also updated its sum-of-the-parts valuation for Array.
On May 8, 2026, Array Digital Infrastructure, Inc. reported Q1 continuing operations EPS of $2.08, compared to 5c last year. Revenue totaled $52.0M, up from $27.0M last year. President and CEO Anthony Carlson said Array is executing on its 2026 priorities, citing tower operations optimization, new colocation applications, steady tower tenancy growth, pending spectrum transactions, and support for T-Mobile’s integration.
Array Digital Infrastructure, Inc. expects FY26 revenue of $200M-$215M, adjusted EBITDA of $200M-$215M, and capital expenditures of $25M-$35M.
Array Digital Infrastructure, Inc. owns and operates shared wireless communications infrastructure in the United States.
6. ASE Technology Holding Co., Ltd. (NYSE:ASX)
On May 26, 2026, ASE Technology Holding Co., Ltd. (NYSE:ASX)’s Advanced Semiconductor Engineering announced the development of an automated 310mm x 310mm panel-level packaging production line. The company said the line supports next-generation advanced packaging technologies and enables a transition from wafer-level packaging to panel-level packaging while preserving design rule consistency across FOCoS and FOCoS-Bridge platforms. The new panel line is expected to enter production in the first half of 2027.
On May 8, 2026, ASE Technology reported April revenue of $1.96B, up 23.1%. April ATM revenue totaled $1.27B, up 33.6%.
Last month, ASE Technology Holding Co., Ltd. reported Q1 net revenue of NT$173,662 million, up 17.2% year-over-year. Net income attributable to shareholders of the parent totaled NT$14,148 million, up from NT$7,554 million in 1Q25. Basic EPS was NT$3.24, or US$0.205 per ADS, while diluted EPS was NT$3.08, or US$0.195 per ADS.
ASE Technology Holding Co., Ltd. provides semiconductor manufacturing services across the United States, Taiwan, the rest of Asia, Europe, and international markets.
5. The Boeing Company (NYSE:BA)
On May 29, 2026, The Boeing Company (NYSE:BA) was awarded a maximum $528.32M modification to a definitized delivery order issued against a three-year basic ordering agreement for a performance-based support contract. The award was a sole-source acquisition, with performance expected to be completed by September 16, 2027. The military services using the contract are the Air Force, Army, Navy, and Marine Corps, with fiscal 2026 defense working capital funds used for the appropriation.
On May 27, 2026, The Boeing Company was awarded an $854.67M modification to a firm-fixed-price, cost-plus-fixed-fee contract. The modification adds scope for the production and delivery of four P-8A Lot 13 aircraft to Foreign Military Sale customers, along with additional non-recurring engineering tied to P-8A diminishing manufacturing sources and material shortages, software integration, and hardware updates for the Navy and FMS customers. Work is expected to be completed by September 2030.
On May 18, 2026, Citi raised the firm’s price target on The Boeing Company to $260 from $256 and maintained a Buy rating on the shares. Citi updated models across aerospace and defense and said it does not expect an “immediate V-shaped rally” without a resolution to the Middle East conflict. The firm still sees buying opportunities after recent selloffs and expects aerospace to rally before defense.
The Boeing Company designs, develops, manufactures, sells, services, and supports commercial jetliners, military aircraft, satellites, missile defense, human space flight and launch systems, and services worldwide.
4. Upstart Holdings, Inc. (NASDAQ:UPST)
On May 27, 2026, Upstart Holdings, Inc. (NASDAQ:UPST) announced that Community Choice Credit Union, or CCCU, partnered with Upstart to offer personal loans to more consumers. Devin Neu, Vice President of Consumer Lending at Community Choice Credit Union, said the partnership provides “fast, convenient access” to digital personal lending for members.
In a regulatory filing, Upstart also disclosed that CEO Paul Gu bought 50,000 shares of common stock on May 13 at $27.50 per share, in a transaction valued at $1.375M.
On May 6, 2026, Needham analyst Kyle Peterson lowered the firm’s price target on Upstart Holdings, Inc. to $37 from $40 and maintained a Buy rating on the shares. Peterson said Q1 results were mixed, with revenue above expectations but profitability below consensus as expenses ran heavy during the quarter. Needham said investors may scrutinize the print, though the firm was still impressed with how Upstart has navigated a tighter funding environment and maintained top-line momentum.
Earlier in May, Upstart Holdings, Inc. reported Q1 adjusted EBITDA of $40.5M, compared to $42.6M last year. Revenue totaled $308M, above the consensus estimate of $303.4M. Co-founder and CEO Paul Gu said originations grew 61% and revenue rose 44% year-over-year, keeping the company on track for its full-year outlook. Gu also cited AI model improvements, an application for a national bank charter, and growth in home and auto.
Upstart Holdings, Inc. operates a cloud-based artificial intelligence lending platform in the United States.
3. Star Bulk Carriers Corp. (NASDAQ:SBLK)
On May 22, 2026, Deutsche Bank raised the firm’s price target on Star Bulk Carriers Corp. (NASDAQ:SBLK) to $32 from $31 and maintained a Buy rating on the shares. Deutsche Bank cited an improving dry bulk market following the company’s Q1 earnings beat.
Last month, Jefferies initiated coverage of Star Bulk Carriers Corp. with a Buy rating and a $29 price target. Jefferies launched coverage of the marine transportation industry, saying geopolitics and fleet constraints “remain an ongoing theme.” The firm said it is “increasingly optimistic” on dry bulk, bullish on tankers for 2026, expects a “decent year” for liquefied petroleum gas, is neutral on liquefied natural gas, and remains cautious on containers.
On May 20, 2026, Star Bulk Carriers Corp. reported Q1 adjusted EPS of 56c, ahead of the consensus estimate of 48c. Revenue totaled $281.15M, above the consensus estimate of $223.55M. CEO Petros Pappas said the dry bulk market opened 2026 with “counterseasonal strength,” with Star Bulk generating net income of $58.5 million, EBITDA of $109.7 million, and TCE of $18,493 per vessel per day. Pappas also said the Board approved a dividend of $0.50 per share under its full payout dividend policy and noted that new Kamsarmax vessels are joining the fleet as the company continues disposing of older tonnage.
Star Bulk Carriers Corp. transports dry bulk cargoes through the ownership and operation of dry bulk carrier vessels worldwide.
2. Progyny, Inc. (NASDAQ:PGNY)
On May 26, 2026, Progyny, Inc. (NASDAQ:PGNY) announced that its Board of Directors approved a share repurchase program to buy back up to $200 million of the company’s common stock. The program will be funded through available cash balances.
On May 19, 2026, Canaccord upgraded Progyny, Inc. to Buy from Hold with a price target of $30, up from $19. Canaccord said the company’s “more conservative guidance philosophy” over the past several quarters has rebuilt a track record of beating quarterly estimates. The firm also said Progyny should begin lapping unfavorable comparisons from the transition of care agreement for departing Amazon members in the second half of 2026, which could move revenue growth back to double digits. A day earlier, Barclays raised the firm’s price target on Progyny to $27 from $23 and maintained an Overweight rating after the earnings report, citing better-than-expected utilization and positive early conversations from the current selling season.
Earlier in May, Progyny, Inc. reported Q1 adjusted EPS of 50c, ahead of the consensus estimate of 44c. Revenue totaled $328.5M, above the consensus estimate of $326.51M. CEO Pete Anevski said the company had a “strong start” to the year, with member engagement trending toward the higher end of expectations as people pursued services tied to family building, health, and well-being goals.
Progyny, Inc. provides fertility, family-building, and women’s health benefits solutions in the United States.
1. NVIDIA Corporation (NASDAQ:NVDA)
On May 29, 2026, NVIDIA Corporation (NASDAQ:NVDA) was reportedly facing uncertainty around plans to launch Rubin CPX, an inference-focused graphics processing unit for its Vera Rubin platform, according to The Elec. The report said supply chain activity around the product appears to have stalled. Industry sources said Nvidia had originally planned to release the product in the second half of this year, but has not placed orders or started development activity related to the required memory or substrates.
On May 27, 2026, NVIDIA Corporation CEO Jensen Huang said the company plans to invest about $150B per year in Taiwan, Reuters’ Wen-Yee Lee reported. Huang described Taiwan as the “epicentre” of the AI revolution and said Nvidia’s annual spending in Taiwan has grown from about $10B-$15B four or five years ago to $100B, with plans to reach $150B each year.
Also on May 27, Tigress Financial raised the firm’s price target on NVIDIA Corporation to $425 from $360 and maintained a Strong Buy rating on the shares. Tigress called Nvidia “the core infrastructure engine of the AI factory era” and a “must-own core holding for the AI investment cycle.”
NVIDIA Corporation operates as a data center-scale AI infrastructure company through its Compute & Networking and Graphics segments.
READ NEXT: 15 High Growth Stocks to Buy and Hold for the Next Decade and 12 Strong Buy Stocks to Buy and Hold for the Next 5 Years
